RT @SatyenGohil@twitter.com

Great work investigating #CLL and transformation to #Richters from @ErinMParry@twitter.com, CathyWu and @getz_lab@twitter.com @gaddyg@twitter.com. Real insights into disease biology of this hard to treat lymphoma and why it's harder to treat compared to #DLBCL @NatureMedicine@twitter.com
https://www.nature.com/articles/s41591-022-02113-6

🐦🔗: https://twitter.com/SatyenGohil/status/1612594860485234688

Happy to share a review article on PI3K inhibitors in #CLL, written with #JenniferBrown at Dana-Farber Cancer Institute. Just published in #Haematologica.

“PI3K inhibitors in chronic lymphocytic leukemia: where do we go from here?”
📌 https://haematologica.org/article/view/haematol.2022.281266

Happy to share a review article on PI3K inhibitors in #CLL, written with #JenniferBrown at Dana-Farber Cancer Institute. Just published in #Haematologica.

“PI3K inhibitors in chronic lymphocytic leukemia: where do we go from here?”
📌 https://haematologica.org/article/view/haematol.2022.281266

I have truly enjoyed the academic network on Twitter for several years. But now it’s time to try another platform. I hope I find many of my colleagues and friends in here!
#precisionmedicine #functionalprecisionmedicine #cll #hematology #medicine #biology

I have truly enjoyed the academic network on Twitter for several years. But now it’s time to try another platform. I hope I find many of my colleagues and friends in here!
#precisionmedicine #functionalprecisionmedicine #cll #hematology #medicine #biology

RT @getz_lab@twitter.com

Hot off the press! Check out our new ms in collaboration with Dr. Catherine Wu’s lab at @DanaFarber@twitter.com #DFCI and colleagues from Spain, Germany and the US on creating a molecular map of #CLL from #multiomics data of >1100 patients that improves prognostics!
https://www.nature.com/articles/s41588-022-01140-w

🐦🔗: https://twitter.com/getz_lab/status/1555270457502359555